Vice President, Business Development

Overview

Halozyme is reinventing the patient experience and building the future of drug delivery. We are passionate about the important work we do and strive to innovate for the future. We embrace transformation and work hard to innovate for the future. We do this together, as One Team. We rise by lifting others up and believe in the power of working together for the collective win.

Join us as a Vice President, Business Development and you'll be part of a culture that welcomes diversity, thinks differently to solve problems, works collaboratively as one team, and delivers meaningful innovations that impact people’s lives.

In this role, you will help move Halozyme’s Business Development efforts for the ENHANZE licensing franchise and our SC delivery technologies in the Halozyme portfolio. This is a key leadership role in the identification, evaluation, negotiation, and execution of new Halozyme business. You will lead and support various strategic projects related to Halozyme strategy and growth, blending deep scientific literacy with strategic, commercial, and relationship-building excellence.

The Vice President, Business Development drives Halozyme's Business Development efforts for the ENHANZE licensing franchise and our small and large volume auto-injectors and other SC delivery technologies in the Halozyme portfolio. This is a key leadership role in the identification, evaluation, negotiation, and execution of new Halozyme business. They will lead and support various other strategic projects related to Halozyme strategy and growth blending deep scientific literacy with strategic, commercial, and relationship-building excellence.

• Contribute toward the development of the Halozyme SC delivery technology Business Development strategies to grow the drug delivery business

• Identify potential new collaborations through self and team directed opportunity analyses, business meetings and reading of new publications and data

• Develop and demonstrate a strong technical knowledge of Halozyme SC delivery technology platforms with ability to translate complex science into clear value propositions for partners and internal executives

• Develop and implement plans to engage key stakeholders and decision-makers within the companies where potential opportunities exist, winning opportunities with communication of well thought through and compelling value propositions, supported by technical and commercial analyses.

• CDA and MTA agreement negotiation efforts required to progress deal flow

• Advance deal negotiations including development of draft Collaboration and Licensing Agreements including gaining internal alignment on proposed terms based on opportunity assessment, leading the negotiation, including tracking and resolving issues through discussion with internal partners, and building agreement with external counterparts

• Develop deep knowledge of market and competitive landscapes and trends, major product developments, trial outcomes, and company activity in the relevant areas of interest

• Regularly update and strengthen the Halozyme SC delivery technology non-confidential and confidential partnering materials and be proficient in presenting this material to prospective partners and responding to questions

• Perform financial and market modeling, creating presentation slides to support strategy and business development decisions

• Lead or support other internal business development partnering and strategic projects that may be outside the scope of Halozyme SC technologies

• Minimum Bachelor s degree in a business, quantitative, or life sciences field; with 18 years of relevant experience. Master s and/or PhD preferred (an equivalent combination of experience and education may be considered)

• Minimum of 12 years  experience in a pharmaceutical/biotech company or healthcare focused consulting role

• Previous business development experience, including experience with evaluation activities such as market assessments, financial modeling, business case development and contract generation

• Corporate accounts and direct selling…